Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001610618-17-000075
Filing Date
2017-11-28
Accepted
2017-11-27 17:48:34
Documents
2

Document Format Files

Seq Description Document Type Size
1 FINAL PROSPECTUS a424b32017-11x20.htm 424B3 131216
2 cdtxlogosec.jpg GRAPHIC 63449
  Complete submission text file 0001610618-17-000075.txt   219700
Mailing Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121 858-752-6170
Cidara Therapeutics, Inc. (Filer) CIK: 0001610618 (see all company filings)

EIN.: 461537286 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-221535 | Film No.: 171223744
SIC: 2836 Biological Products, (No Diagnostic Substances)